The Vanguard Group just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13G. In the filing, it appears as though The Vanguard Group claims to own 11,198,268 shares. This represents 6.84% of PDL BioPharma.

Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.

To receive a free e-mail notification whenever PDL BioPharma makes a similar move, sign up!

Other recent filings from the company include the following:

Regulation FD - Feb. 21, 2018
Pdl Biopharma Terminates Interest In Pursuing Acquisition Of Neos - Feb. 20, 2018
Renaissance Technologies LLC just provided an update on share ownership of PDL BioPharma - Feb. 14, 2018
STATE STREET CORPORATION just provided an update on share ownership of PDL BioPharma - Feb. 14, 2018
The Vanguard Group just provided an update on share ownership of PDL BioPharma - Feb. 9, 2018

Auto Refresh

Feedback